Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BGLC NASDAQ:BRTX NASDAQ:MGRX OTCMKTS:MITI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBGLCBioNexus Gene Lab$2.04$2.33$1.92▼$15.60$4.93M4.093,620 shs1,506 shsBRTXBiorestorative Therapies$0.25+5.0%$0.25$0.19▼$2.05$6.17M0.291.34 million shs1.39 million shsMGRXMangoceuticals$0.32-5.4%$0.39$0.16▼$2.75$5.74M2.12649,976 shs569,452 shsMITIMitesco$0.08+9.9%$0.10$0.04▼$0.45$1.47M4.97209,182 shs71,549 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBGLCBioNexus Gene Lab0.00%-2.39%-7.69%-13.19%-25.00%BRTXBiorestorative Therapies+8.87%+13.95%-8.63%-75.34%-86.49%MGRXMangoceuticals+0.63%-11.19%-5.38%-10.14%-82.33%MITIMitesco+18.31%+11.29%-14.56%+39.82%-79.31%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBGLCBioNexus Gene Lab$2.04$2.33$1.92▼$15.60$4.93M4.093,620 shs1,506 shsBRTXBiorestorative Therapies$0.25+5.0%$0.25$0.19▼$2.05$6.17M0.291.34 million shs1.39 million shsMGRXMangoceuticals$0.32-5.4%$0.39$0.16▼$2.75$5.74M2.12649,976 shs569,452 shsMITIMitesco$0.08+9.9%$0.10$0.04▼$0.45$1.47M4.97209,182 shs71,549 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBGLCBioNexus Gene Lab0.00%-2.39%-7.69%-13.19%-25.00%BRTXBiorestorative Therapies+8.87%+13.95%-8.63%-75.34%-86.49%MGRXMangoceuticals+0.63%-11.19%-5.38%-10.14%-82.33%MITIMitesco+18.31%+11.29%-14.56%+39.82%-79.31%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBGLCBioNexus Gene Lab 1.00SellN/AN/ABRTXBiorestorative Therapies 1.00SellN/AN/AMGRXMangoceuticals 1.00SellN/AN/AMITIMitesco 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest MITI, MGRX, BRTX, and BGLC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/27/2026MGRXMangoceuticals Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 5/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBGLCBioNexus Gene Lab$7.43M0.66N/AN/A$3.56 per share0.57BRTXBiorestorative Therapies$360K17.98N/AN/A$0.04 per share6.35MGRXMangoceuticals$460K11.80N/AN/A$0.93 per share0.34MITIMitesco$40K40.26$0.03 per share2.25($1.36) per share-0.06Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBGLCBioNexus Gene Lab-$2.98M-$1.28N/AN/AN/A-40.19%-38.85%-33.36%N/ABRTXBiorestorative Therapies-$14.24M-$1.59N/AN/AN/A-3,956.11%-430.91%-203.61%5/13/2026 (Estimated)MGRXMangoceuticals-$20.64M-$2.56N/AN/AN/A-4,536.70%-109.38%-102.40%N/AMITIMitesco$500K-$0.36N/AN/AN/A-7,638.20%-2.18%303.55%N/ALatest MITI, MGRX, BRTX, and BGLC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q1 2026BRTXBiorestorative Therapies-$0.20N/AN/AN/A$0.31 millionN/A4/14/2026Q4 2025BGLCBioNexus Gene LabN/A-$0.52N/A-$0.52N/A$0.48 million4/1/2026Q4 2025MGRXMangoceuticalsN/A$0.13N/A$0.27N/A$0.09 million3/26/2026Q4 2025BRTXBiorestorative Therapies-$0.37-$0.37N/A-$0.32$0.15 million$0.02 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBGLCBioNexus Gene LabN/AN/AN/AN/AN/ABRTXBiorestorative TherapiesN/AN/AN/AN/AN/AMGRXMangoceuticalsN/AN/AN/AN/AN/AMITIMitescoN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBGLCBioNexus Gene LabN/A10.469.16BRTXBiorestorative TherapiesN/A0.840.84MGRXMangoceuticalsN/A1.741.74MITIMitescoN/A0.010.01Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBGLCBioNexus Gene Lab18.85%BRTXBiorestorative Therapies69.38%MGRXMangoceuticals56.72%MITIMitesco0.01%Insider OwnershipCompanyInsider OwnershipBGLCBioNexus Gene Lab0.05%BRTXBiorestorative Therapies13.60%MGRXMangoceuticals16.00%MITIMitesco4.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBGLCBioNexus Gene Lab302.42 million2.42 millionNot OptionableBRTXBiorestorative Therapies725.48 million22.01 millionNot OptionableMGRXMangoceuticals316.97 million14.25 millionNot OptionableMITIMitesco3020.94 million19.92 millionNot OptionableMITI, MGRX, BRTX, and BGLC HeadlinesRecent News About These CompaniesMitesco, Inc. Announces Launch of Video Highlighting Strategic Partner Sportzfolio PlatformApril 9, 2026 | markets.businessinsider.comMitesco, Inc. Updates Shareholders on Acquisitions, Data Center Target Sites and Executive AppointmentsMarch 10, 2026 | finance.yahoo.comMitesco Announces Financing Partnership to Accelerate Centcore Data Center Expansion and Software Acquisition StrategyFebruary 17, 2026 | finance.yahoo.comMitesco Unveils RoboAgent AI Real Estate PrototypeFebruary 2, 2026 | tipranks.comMitesco, Inc. Announces RoboAgent Prototype Ready for Live Demo and Releases New Investor Introduction VideoJanuary 27, 2026 | finance.yahoo.comMitesco's Centcore Sets Sights on Tennessee for Data Center Expansion, Possible Acquisitions and AIDecember 10, 2025 | finance.yahoo.comMitesco Partners with JRB Consulting for Strategic GrowthDecember 3, 2025 | msn.comMitesco Accelerates A.I. Advancements, Eyes Strategic Mergers and Uplisting PathDecember 1, 2025 | finance.yahoo.comUnited Home Loans, LLC Engages Mitesco, Inc. for Advanced Digital Marketing CampaignOctober 13, 2025 | finance.yahoo.comMitesco Expands A.I. Based Sales Automation to Include Mortgage, Insurance IntegrationOctober 1, 2025 | finance.yahoo.comMitesco Expands Operations with New InitiativesSeptember 23, 2025 | tipranks.comMitesco Announces New Managed Services Offerings, Expanded Application Software Team and Addition of Digital Currency ExpertsSeptember 18, 2025 | theglobeandmail.comMitesco’s Centcore Partners with Sportzfolio for Pickleball PlatformSeptember 9, 2025 | tipranks.comMitesco Highlights Strategic Expansion in Data Center Operations and Launch of AI-Powered Sales Automation PlatformAugust 19, 2025 | finance.yahoo.comMitesco Advances on Robo-Agent A.I. Project for Sales Automation, Follow-up-Boss Integration, Major Agencies Engaged in Test BedJune 18, 2025 | finance.yahoo.comSentry RMS by Accucom Chooses Centcore Data Center for Cloud InstallationJune 10, 2025 | finance.yahoo.comMitesco Expands Board, Updates on Centcore Data Services and New A.I. ApplicationsMay 30, 2025 | theglobeandmail.comEQS-News: Mitesco Expands Board, Updates on Centcore Data Services and New A.I. ApplicationsMay 29, 2025 | finanzen.atFEQS-News: Mitesco, Inc. and United Powers, LLC Enter Strategic VAR PartnershipApril 2, 2025 | markets.businessinsider.comMitesco, Inc. and United Powers, LLC Enter Strategic VAR PartnershipApril 2, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMITI, MGRX, BRTX, and BGLC Company DescriptionsBioNexus Gene Lab NASDAQ:BGLC$2.04 0.00 (0.00%) Closing price 05/5/2026 03:48 PM EasternExtended Trading$2.04 +0.00 (+0.25%) As of 05/5/2026 06:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.Biorestorative Therapies NASDAQ:BRTX$0.25 +0.01 (+4.96%) Closing price 05/5/2026 04:00 PM EasternExtended Trading$0.25 0.00 (0.00%) As of 05/5/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. The company was incorporated in 1997 and is based in Melville, New York.Mangoceuticals NASDAQ:MGRX$0.32 -0.02 (-5.38%) Closing price 05/5/2026 04:00 PM EasternExtended Trading$0.33 +0.01 (+2.56%) As of 05/5/2026 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.Mitesco OTCMKTS:MITI$0.08 +0.01 (+9.86%) As of 05/5/2026 03:45 PM EasternMitesco, Inc. does not have significant operations. Previously, it was engaged in healthcare technology and services business. Mitesco, Inc. is based in Vero Beach, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir Drops After a Blowout Q1—What Investors Should Know Shopify’s Valuation Crisis Creates Opportunity in 2026 onsemi Stock Dips After Earnings: Why the Dip Is Buyable TSLA: 3 Reasons the Stock Could Hit $400 in May Nebius Breaks Out to All-Time Highs—Here's What's Driving It. 3 Reasons Analysts Love DexCom The Great Chip Divide: AI Chip War Pivots from Hype to Execution Atomic Dividends: Big Tech's New Energy Bet Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
